メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
川部 直人
医学部・消化器内科学・第１
h-index
1367
被引用数
18
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2006
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(60)
類似のプロファイル
(7)
フィンガープリント
Naoto Kawabeが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Bevacizumab
46%
Atezolizumab
46%
Nonalcoholic Fatty Liver
33%
Sclerosing Cholangitis
23%
Sorafenib
23%
Adverse Event
23%
Hepatitis B Antigen
21%
Chronic Hepatitis C
20%
Phospholipase
19%
Overall Survival
19%
Disease
19%
Progression Free Survival
18%
Alpha Fetoprotein
18%
Liver Disease
15%
Liver Cirrhosis
15%
Hepatitis B(e) Antigen
14%
Combination Therapy
13%
Malignant Neoplasm
13%
Antiviral Therapy
11%
Hepatitis B Virus
11%
Chronic Hepatitis B
11%
Extrahepatic Bile Duct Obstruction
11%
Immunoglobulin G4
11%
Small Interfering RNA
11%
Alpha Tocopherol
11%
Lenvatinib
11%
Hypoalbuminemia
11%
Chemotherapy
11%
Hepatitis C
11%
Branched Chain Amino Acid
11%
Steroid Treatment
11%
Cabozantinib
11%
Diabetic Nephropathy
11%
Interferon
11%
Nalfurafine
11%
Portal Vein Thrombosis
11%
Rifaximin
11%
Recurrent Disease
11%
Cisplatin
11%
Portopulmonary Hypertension
11%
Peginterferon
11%
Ramucirumab
11%
Chronic Hepatitis
11%
Diabetes Mellitus
11%
Erythropoietic Protoporphyria
11%
Creatinine
11%
Focused Ion Beam
10%
Ribavirin
10%
Aspartate Aminotransferase
9%
Medicine and Dentistry
Endoscopic Ultrasound
46%
Hepatocellular Carcinoma
41%
Immunoglobulin G4
35%
Sclerosing Cholangitis
35%
Neoplasm
32%
Chronic Hepatitis C
32%
Liver Cirrhosis
27%
Acoustic Radiation
23%
Cystic Pancreatic Lesion
23%
Malignant Neoplasm
15%
Pancreas Adenocarcinoma
15%
Liver Disease
14%
Hepatitis C Virus
14%
Pancreas Tumor
14%
Steroid Treatment
14%
Intraductal Papillary Mucinous Tumor
14%
Liver Biopsy
13%
Transient Elastography
13%
Biopsy
13%
Bile Duct
13%
Autoimmune Pancreatitis
12%
Diagnosis
12%
Chronic Hepatitis B
11%
Extrahepatic Bile Duct Obstruction
11%
Hypoalbuminemia
11%
Polyp
11%
MALT Lymphoma
11%
Branched Chain Amino Acid
11%
Confocal Laser Scanning Microscopy
11%
Transcatheter Arterial Chemoembolization
11%
Bevacizumab
11%
Chronic Hepatitis
11%
Interferon
11%
Biloma
11%
Cholestasis
11%
Cisplatin
11%
Intraarterial Drug Administration
11%
Immunoglobulin
11%
Cancer Risk
11%
Cholangitis
11%
Steroid Therapy
11%
Portal Vein Thrombosis
11%
Synapsin II
11%
Nalfurafine
11%
Somatomedin B
11%
Fibrosis
11%
Hepatitis C
11%
Diabetic Nephropathy
11%
Rifaximin
11%
Portopulmonary Hypertension
11%
Keyphrases
Atezolizumab Plus Bevacizumab
35%
Advanced Hepatocellular Carcinoma
23%
Clinical Outcomes
23%
Intraductal Papillary mucinous Neoplasm
14%
Endoscopic Ultrasonography
14%
Chronic Hepatitis B
11%
Antiretroviral Therapy
11%
Liver Stiffness
11%
Transabdominal
11%
Bilirubin
11%
Intrahepatic Cholestasis
11%
Branched-chain Amino Acid Granules
11%
Acoustic Radiation Force Impulse Elastography
11%
Acoustic Radiation Force Impulse
11%
Contrast-enhanced Harmonic Endoscopic Ultrasonography
11%
Intervention System
11%
IgG4-related Sclerosing Cholangitis
11%
Promising Treatment
11%
Medical Ultrasonics
11%
Biloma
11%
Capsid Assembly Modulators
11%
JNJ-56136379
11%
Branched-chain Amino Acid Ratio
11%
I148M
11%
PNPLA3
11%
Hepatitis B Envelope Antigen
11%
Randomized Prospective Trial
11%
Tumor Assessment
11%
Nutritional Status Assessment
11%
Cabozantinib
11%
Domain Sensitivity
11%
EIF2α Phosphorylation
11%
Shear Wave Velocity
11%
Interferon-based Therapy
11%
Steroid Therapy
11%
Previously Treated
11%
Stiffness Index
11%
Chronic Pruritus
11%
Nalfurafine Hydrochloride
11%
Intrahepatic Distant Recurrence
11%
Efficacy Predictor
11%
Pegylated Interferon Therapy
11%
Rifaximin
11%
Portopulmonary Hypertension
11%
Combination Therapy
11%
Lenvatinib
11%
Fatty Liver Disease Index
11%
Ramucirumab
11%
Pancreatic Neoplasms
11%
Pancreatic Cyst
11%
